Publications by authors named "Frank Duff"

Claim this Profile
E
Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study.
Onyema Ogbuagu, Jason D Goldman, Robert L Gottlieb, Upinder Singh, Masaharu Shinkai, Frank Duff

Lancet Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients with COVID-19 (BIRCH): a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.
Anca Streinu-Cercel, Antonella Castagna, Shan-Chwen Chang, Yao-Shen Chen, Yiannis Koullias, Frank Duff

Clin Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
Robert L Gottlieb, Carlos E Vaca, Roger Paredes, Jorge Mera, Brandon J Webb, Frank Duff

N Engl J Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirin.
Michael W Fried, Donald M Jensen, Maribel Rodriguez-Torres, Lisa M Nyberg, Adrian M Di Bisceglie, Frank Duff

Hepatology· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin.
Eric Snoeck, Janet R Wade, Frank Duff, Matthew Lamb, Karin Jorga

Br J Clin Pharmacol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of ribavirin in patients with hepatitis C virus.
Janet R Wade, Eric Snoeck, Frank Duff, Matthew Lamb, Karin Jorga

Br J Clin Pharmacol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy.
Stefan Mauss, William Valenti, Jean DePamphilis, Frank Duff, Lisa Cupelli

AIDS· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
Francesca J Torriani, Maribel Rodriguez-Torres, Jürgen K Rockstroh, Eduardo Lissen, Juan Gonzalez-García, Frank Duff

N Engl J Med· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection.
Sibylle Grub, Patricia Delora, Eric Lüdin, Frank Duff, Courtney V Fletcher

Clin Pharmacol Ther· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis